CMKLR1 and familial dilated cardiomyopathy: Furthermore, both the systolic and diastolic dysfunction of the left ventricle were improved in CMKLR1-siRNA-treated DCM rats, as evidenced by the attenuated hypertrophy, reduced fibrosis, decreased cardiac pyroptosis, and reduced myocardial lipid deposition.